Key result
TEVAR shows no in-hospital mortality benefit over open repair but has higher long-term reintervention rates.
Why the study?
The long-term complication rates of open repair and thoracic endovascular aortic repair (TEVAR) have not yet been determined.
Does TEVAR compared to open repair improve outcomes in patients with descending thoracic aortic pathologies?
Cohort (n=136)
No
Does TEVAR compared to open repair improve outcomes in patients with descending thoracic aortic pathologies?
Absolute Event Rate: 3.3% vs 11.1%
p-value: p=0.068
TEVAR offers shorter hospital stays and similar long-term survival compared to open repair for descending thoracic aortic pathologies, but is associated with a higher rate of aortic reinterventions.
TEVAR may be considered for descending thoracic aortic repair in select patients; leaves open durability questions without randomized confirmation.
BACKGROUND: The long-term complication rates of open repair and thoracic endovascular aortic repair (TEVAR) have not yet been determined. Therefore, this study aimed to compare the long-term outcomes and aortic reintervention rates between open repair and TEVAR in patients with descending thoracic aortic pathologies. METHODS: Between January 2002 and December 2017, 230 patients with descending thoracic aortic pathologies underwent surgery. Of these, 136 patients were included in this retrospective study: 45 patients (10, 2, and 33 with dissection, penetrating atherosclerotic ulcer, and pseudoaneurysm, respectively) underwent open repair and 91 patients (27, 1, and 63 with dissection, penetrating atherosclerotic ulcer, and pseudoaneurysm, respectively) underwent TEVAR. The primary end points were in-hospital mortality, and short-term complications. The secondary end points were long-term mortality and reintervention rates. Based on the propensity score matching (PSM), 35 patients who underwent open repair were matched to 35 patients who underwent TEVAR (ratio = 1:1). RESULTS: The mean follow-up period was 70.2 ± 51.9 months. Shorter intensive care unit and hospital stay were seen in the TEVAR group than in the open repair group before and after PSM (p < 0.001 and p < 0.001, respectively). However, in-hospital mortality, and spinal cord ischemia were not significantly different among the two groups (before PSM: p = 0.068 and p = 0.211, respectively; after PSM: p = 0.303 and p = 0.314, respectively). The cumulative all-cause death and aorta-related death showed no significant differences between the two groups (before PSM: p = 0.709 and p = 0.734, respectively; after PSM: p = 0.888 and p = 0.731, respectively). However, aortic reintervention rates were higher in the TEVAR group than in the open repair group before and after PSM (p = 0.006 and p = 0.013, respectively). CONCLUSION: The TEVAR group was superior in short-term recovery outcomes but had higher reintervention rates compared to the open repair group. However, there were no significant differences in long-term survival between the two groups.
No takes yet. Share an insight, caveat, or question.
Son et al. (2020) conducted a cohort in Descending thoracic aortic pathologies (n=136). Thoracic endovascular aortic repair (TEVAR) vs. Open repair was evaluated on In-hospital mortality (p=0.068). Thoracic endovascular aortic repair was associated with a non-significant difference in in-hospital mortality (3.3% vs 11.1%, p=0.068) compared to open repair, but had higher long-term reintervention rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: